Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating CD19 t-haNK and NAI with Rituximab in relapsed indolent non-Hodgkin lymphoma; the study is not yet recru…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CD79b-19 CAR T cells for relapsed or refractory non-Hodgkin lymphoma, including several subtypes, is cur…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T [Phase 2]
Phase 2 clinical trial evaluating Odronextamab for relapsed or refractory large B-cell lymphomas before CAR-T therapy; the study is currentl…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders [Phase 2]
Phase 2 clinical trial evaluating cord blood transplant in children and young adults with blood cancers and select non-malignant disorders; …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Odronextamab in Low Tumor Volume Advanced FL [Phase 2]
Phase 2 study evaluating odronextamab for low-tumor-volume advanced follicular lymphoma is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy [Phase 2]
A Phase 2 clinical trial evaluating epcoritamab for patients with follicular lymphoma who did not achieve a complete response to upfront che…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies [Phase 1]
Phase 1 clinical trial update of BGB-21447, a Bcl-2 inhibitor developed by BeOne Medicines, evaluating safety and preliminary activity in mu…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Long-Term Follow-up Study
Long-term follow-up study of relapsed/refractory non-Hodgkin lymphoma is currently enrolling by invitation, sponsored by Caribou Biosciences…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases [NA]
This entry reports an ongoing clinical trial evaluating myeloablative preparative regimens for umbilical cord blood transplantation across s…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating CMV-MVA Triplex vaccination in HLA-matched related stem cell donors to prevent cytomegalovirus infection i…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) [Phase 1]
Dizal Pharmaceuticals is conducting a Phase 1 mass-balance pharmacokinetic study of DZD8586 in healthy male participants (TAI-SHAN15); the t…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: PIC1 Injection Therapy for Relapsed/Refractory B-NHL [Phase 1]
Phase 1 clinical trial of PIC1 Injection Therapy for relapsed/refractory B-cell non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
A clinical trial update notes a study evaluating chemotherapy-induced cognitive disorders in patients treated for hematological malignancies…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas [Phase 1, Phase 2]
Clinical trial update for SB-4826 in adults with locally advanced or metastatic solid tumors or non-Hodgkin lymphoma, currently recruiting i…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy [Phase 3]
A Phase 3 trial compares Ronde-cel CD19 CAR T-cell therapy against investigator's choice CD19 CAR T-cell therapy in adults with large B-cell…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CHO-H01 as a single agent or in combination with lenalidomide for refractory or relapsed Non-Hodgkin l…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome [Phase 2]
A Phase 2 clinical trial update evaluating the combination of zanubrutinib and lisocabtagene maraleucel for Richter's syndrome, with patient…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of Oral LOXO-338 in Patients With Advanced Blood Cancers [Phase 1]
Phase 1 study of oral LOXO-338 in advanced blood cancers is ongoing, with status listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes (GRALE) for EBV-positive lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib [Phase 4]
This document describes a Phase 4 master protocol studying the long-term safety of Pirtobrutinib (LY3527727). The study is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma [Phase 4]
This clinical trial update reports a Phase 4 study of pirtobrutinib (LY3527727) in previously treated chronic lymphocytic leukemia/small lym…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study
This clinical trial update describes the Mayo Clinic LEO Study evaluating prognosis and survivorship in recently diagnosed patients with Non…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies [Phase 1, Phase 2]
A first-in-human study evaluating HLA partially to fully matched allogeneic, cryopreserved deceased donor bone marrow transplantation for va…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma [Phase 1]
Phase 1 trial update of ViPOR-P (venetoclax, ibrutinib, prednisone, obinutuzumab, lenalidomide) in combination with polatuzumab for relapsed…